£15.8 million UK haul of fake drugs
June 19, 2015Manufacturing and Production, Sales and Marketing MHRA, counterfeit, drugs, fake, interpol
Counterfeit and unlicensed medicines and devices worth £15.8 million have been seized in the UK as part of a global …
Health wearable Fitbit leads the market
June 19, 2015Medical Communications, Sales and Marketing Apple, brett wells, digital, fitbit, health, watch, wearables
Health and fitness wearable device Fitbit has beaten expectations as the company’s shares soar following its first day of trading …
Zeus Capital names healthcare finance lead
June 19, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing phil walker, zeus capital
Investment banking boutique Zeus Capital is increasing its healthcare sector team by hiring Phil Walker to head the firm’s healthcare …
NICE wants more answers from Gilead on Zydelig
June 18, 2015Sales and Marketing Gilead, MabThera, NICE, Roche, UK, brett wells, zydelig
The National Institute for Health and Care Excellence has not recommended Gilead’s leukaemia drug Zydelig in draft guidance. But the …
EU approval for new Sanofi, Merck vaccine
June 18, 2015Sales and Marketing EU, Europe, Merck, Sanofi, Sanofi pasteur msd, brett wells, gardasil 9
Sanofi and Merck are looking forward to a successor to their blockbuster Gardasil now that the European Commission has granted …
No ‘Plan B’ for Obamacare
June 18, 2015Medical Communications, Sales and Marketing ACT, Medicaid, Medicare, Obama, Obamacare, patient protection
US president Barack Obama has no ‘Plan B’ if a crucial Supreme Court vote in the next fortnight goes against …
NHS England unveils digital roadmap
June 17, 2015Medical Communications, Sales and Marketing GP, HSCIC, NHS, NIB, brett wells, choices, digital, wearables
NHS England has laid out digital technology plans that it says will completely transform services and improve health outcomes using …
AZ takes manufacturing head from Merck
June 17, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing
Pam Cheng has joined AstraZeneca from Merck to be its executive vice president of operations and IT. Cheng succeeds David …
GSK ploughs $95m into research institute
June 17, 2015Research and Development, Sales and Marketing GSK, Pfizer, acquisition, altius, merger, takeover
GlaxoSmithKline is pouring $95 million into a new US research institute to investigate how a cell’s operating system works in …
Immodulon Therapeutics makes two senior hires
June 17, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Immodulon Therapeutics
UK late-stage biopharma firm Immodulon Therapeutics has made two new senior appointments to its board of directors. Investment fund manager …
Actavis changes its name to Allergan
June 16, 2015Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Valeant
Actavis has now officially changed its name to Allergan following the Ireland-based company’s recent acquisition of the botox maker. This …
Pfizer expands in China with $95m consumer products plant
June 16, 2015Manufacturing and Production, Sales and Marketing Asia, China, Pfizer, brett wells, production
Pfizer says it has broken ground with a $95 million production facility in Suzhou in China to expand its production …
FDA links with PatientsLikeMe
June 16, 2015Medical Communications, Sales and Marketing FDA, PatientsLikeMe, data
The US Food and Drug Administration has signed a research deal with PatientsLikeMe in a move the online patient network …
Rock Unlimited appoints director
June 16, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing ben fisher, rock unlimited
Communications firm Rock Unlimited has appointed a new director to its team in Ben Fisher. Fisher takes to the firm …
FDA accepts Teva asthma drug for review
June 15, 2015Sales and Marketing AstraZeneca, GlaxoSmithKline’s mepolizumab, Teva, benralizumab, bla, cinquil, reslizumab
Teva’s investigational biologic for the treatment of inadequately controlled asthma in patients with elevated blood eosinophils, Cinquil, has been accepted …
Bayer promotes Xarelto benefits
June 15, 2015Sales and Marketing Bayer, Eliquis, Xarelto, blood, law suits, rivaroxaban
Bayer HealthCare is releasing new evidence to suggest that the risk of taking its best-selling blood thinner Xarelto is outweighed …
Consumer watchdog highlights FDA failures
June 15, 2015Manufacturing and Production, Research and Development, Sales and Marketing FDA, brett wells, hetlioz, public citizen
Consumer watchdog Public Citizen has criticised the FDA for incorrectly expanding the use of Vanda Pharma’s sleep disorder drug Hetlioz …
Amgen bets on immunotherapy future
June 15, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Amgen, immunotherapy, oncology, oncolytic, tom lillie
When we speak to Tom Lillie he’s brimming with excitement about the future for Amgen in oncology and the future …
DrugDev looks to Lilly for chairman role
June 15, 2015Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drugdev, jeffrey kasher, lilly
Dr Jeffrey Kasher has joined US healthcare tech firm DrugDev as the chairman of its advisory board. Kasher takes 28 …
China flu vaccine gets WHO seal of approval
June 12, 2015Research and Development, Sales and Marketing Hualan Biological Bacterin, WHO, influenza
A Chinese influenza vaccine has been deemed safe and effective by The World Health Organization (WHO). The approval makes its …
Latest content
Migraine annual economic and quality-of-life burden in UK
bit.bio expands human heart cell portfolio through myriamed partnership
Phoenix Labs acquires Kent Pharma
Astoriom acquires Sampled’s UK stability storage operations
